Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension
- 1 October 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 34 (4) , 1188-1192
- https://doi.org/10.1016/s0735-1097(99)00312-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Survival in primary pulmonary hypertension. Validation of a prognostic equation.Circulation, 1994
- Orally Administered Beraprost Sodium Inhibits Pulmonary Hypertension Induced by Monocrotaline in Rats.The Tohoku Journal of Experimental Medicine, 1994
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992
- Single-lung transplantation for pulmonary hypertension. Three-month hemodynamic follow-up.Circulation, 1991
- Primary pulmonary hypertension: natural history and the importance of thrombosis.Circulation, 1984
- Heart-Lung TransplantationNew England Journal of Medicine, 1982
- Oral Hydralazine Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1980
- Reliability of the Determination of Cardiac Output in Man by Means of the Fick PrincipleCirculation Research, 1958